Sigwart D F, Stocker B A, Clements J D
Department of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, Louisiana 70112.
Infect Immun. 1989 Jun;57(6):1858-61. doi: 10.1128/iai.57.6.1858-1861.1989.
We made delta aroA, delta purA, and delta aroA delta purA derivatives of a strain of Salmonella dublin and isolated a nalidixate-resistant mutant of each construct. An inoculum of each of the nearly isogenic nalidixate-resistant auxotrophs was administered to BALB/c mice by gavage. The ability of each strain to colonize, invade, persist in tissues, and evoke serum and mucosal antibody responses to the lipopolysaccharide of the parent strain was examined. Only the delta aroA strain colonized, invaded, persisted, and (more importantly) evoked sustained significant serum and mucosal antibody responses. Neither the delta purA nor the delta aroA delta purA strain showed any of these abilities. These observations demonstrate that the purA defect, which causes a requirement for adenine, reduces the live-vaccine efficacy of attenuated Salmonella strains and may limit the effectiveness of Salmonella strains as carriers of heterologous antigens. These findings may be important in the selection of attenuated S. typhi strains for use in humans either as antityphoid live vaccines or as vectors for antigens of other pathogens.
我们构建了都柏林沙门氏菌菌株的ΔaroA、ΔpurA以及ΔaroAΔpurA衍生物,并分离出每种构建体的耐萘啶酸突变体。通过灌胃将每种近乎同基因的耐萘啶酸营养缺陷型菌株接种到BALB/c小鼠体内。检测了每种菌株在组织中定殖、侵袭、持续存在的能力,以及引发针对亲本菌株脂多糖的血清和粘膜抗体反应的能力。只有ΔaroA菌株能够定殖、侵袭、持续存在,并且(更重要的是)引发持续显著的血清和粘膜抗体反应。ΔpurA菌株和ΔaroAΔpurA菌株均未表现出这些能力。这些观察结果表明,导致对腺嘌呤有需求的purA缺陷会降低减毒沙门氏菌菌株的活疫苗效力,并可能限制沙门氏菌菌株作为异源抗原载体的有效性。这些发现对于选择用于人类的减毒伤寒沙门氏菌菌株可能具有重要意义,这些菌株可作为抗伤寒活疫苗或作为其他病原体抗原的载体。